USP15 enzyme emerges as potential target for ovarian cancer treatment

Enzyme USP15 present a promising new target for ovarian cancer treatment

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30%. Further complicating treatment, standard therapies cause substantial harm to healthy cells alongside cancerous ones. But what if ovarian cancer treatment could more specifically target cancerous cells, causing less harm to the rest of the body?

USP15 enzyme emerges as potential target for ovarian cancer treatment

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30 percent.

Enzyme USP15 Limits Ovarian Cancer Cells And Boosts Chemotherapy

Enzyme USP15 Limits Ovarian Cancer Cells And Boosts Chemotherapy Ovarian cancer is devastating, five-year survival rate under 30%, when detected after it has spread. New basic research may improve that. News Sun, 09/27/2026 - 04:29 Categories Cancer Research

UMBC Research Team Discovers Promising Molecular Target For Ovarian Cancer Treatment 2026

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30 percent. Further complicating treatment, standard therapies cause substantial harm to healthy cells alongside cancerous ones. But what if ovarian cancer treatment could more specifically target cancerous cells, causing less harm to the rest of the body? New research from Achuth Padmanabhan’s lab offers …